Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
Clinical trial NCT04432402 · UNKNOWN
Trial details
- NCT number
- NCT04432402
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-14
- Primary completion
- 2022-12-31
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.